Anemia

RBC Transfusions Commonly Lead to Hyperkalemia, Hospitalization in CKD

Publish Date April 13, 2023

Use of intravenous iron and ESAs was low among patients with stage 3 to 5 CKD.

Upper GI Erosions Are the Most Frequent Non-CV Events in the Dialysis Population

Publish Date April 13, 2023

The rate of esophageal and gastric erosions among patients on dialysis eligible for anemia treatment was approximately 49 events per 100 patient-years, investigators report.

Red Blood Cell Transfusion Rate Highest With Persistent ESA Hyporesponse

Publish Date April 13, 2023

Patients receiving peritoneal dialysis rather than hemodialysis or both modalities have the lowest rate of ESA hyporesponse.

ESA Hyporesponse Tied to Adverse Events in Dialysis Population

Publish Date April 12, 2023

Patients with persistent ESA hyporesponse had especially high rates of adverse events.

New Questionnaire Captures Symptoms, Burden of CKD Anemia

Publish Date April 12, 2023

The new tool goes beyond hemoglobin measurement to include the effects of anemia on patients’ quality of life.

Vadadustat Noninferior to Long-Acting ESA for Anemia in Hemodialysis Patients

Publish Date April 10, 2023

Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor.

FDA Approves Oral Daprodustat to Treat Anemia in Dialysis

Publish Date February 3, 2023

The FDA approval of daprodustat is based on results from the ASCEND-D trial comparing daprodustat with ESAs.

Anemia Prevalence, Burden Characterized

Publish Date January 26, 2023

In both men and women, the prevalence of severe anemia increased as kidney function decreased.

What Do We Know About Cancer Risk in Patients With Anemia?

Publish Date January 17, 2023

Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?

HIF-PHIs and ESAs Have Comparable Adverse Effects

Publish Date January 10, 2023

Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.